VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health

Completed

Conditions studied: Renal Transplant Failure

In brief

Ten percent of American adults, more than 20 million people, have chronic kidney disease, which in the advanced state of end stage renal disease is most desirably and cost-effectively treated by kidney transplantation. However, 20-30% of transplanted kidneys fail in living recipients by 10 years, owing largely to insufficient monitoring methods. The goal of the proposed research is to improve noninvasive kidney transplant monitoring using a new ultrasound-based imaging method called Viscoelastic Response (VisR) ultrasound.

Key facts

Study ID

NCT03079882

Run by

University of North Carolina, Chapel Hill

People needed

65

Starts

2016-06-16

Expected to finish

2021-02-28

Last updated by the study team

2021-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years of age
• Selected by treating physician to be in need of renal transplant surgery
• Ability to provide informed consent
• Ability to communicate with pertinent staff
• Ability to understand and comply with study requirements

You may not qualify if…

• Inability to provide valid consent
• Inability to communicate with pertinent staff
• Inability to remain motionless for at least 20 minutes
• Renal transplant deeper than 4 cm

Where it is running

• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.